ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
143 hedge funds and large institutions have $389M invested in iTeos Therapeutics in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 58 increasing their positions, 48 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
143
Holders Change
-2
Holders Change %
-1.38%
% of All Funds
2.28%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
58
Reduced
48
Closed
15
Calls
$7.51M
Puts
$3.25M
Net Calls
+$4.26M
Net Calls Change
+$3.9M
Top Buyers
| 1 |
DM
1
Deerfield Management
New York
|
$7.92M |
| 2 |
2
Janus Henderson Group
London,
United Kingdom
|
$5.48M |
| 3 |
3
BlackRock
New York
|
$55.3M |
| 4 |
SVCM
4
Saturn V Capital Management
Austin,
Texas
|
$10.9M |
| 5 |
IC
5
Ikarian Capital
Dallas,
Texas
|
$3.79M |
